AvoMD
PrivateLast Round
Series A
Mar 31, 2026
Total Funding Raised
$18M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
AvoMD operates in Healthcare & Life Sciences and is based in New York City, New York. Its latest recorded funding round was a Series A round in March 2026.
AvoMD is a healthcare technology company that provides a no-code platform for clinicians and hospitals to build and deploy point-of-care decision support applications.
Sector
Healthcare & Life Sciences
Verticals
EHR & EMR, Medical AI, NLP & Conversational AI, Workflow Automation, Healthcare Analytics
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AvoMD Comparables
Compare AvoMD with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Glass Health | 85% | |
| EvidenceCare | 83% | |
| DeepScribe | 82% |
For institutional investors. Book with your work email.
AvoMD Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Mar 31, 2026 | ||||
| Seed | Jun 23, 2023 | ||||
| Seed | Jul 9, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
AvoMD Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| AlleyCorp | Series A, Seed |
| Epsilon Health Investors | Seed, Series A |
| Mirae Asset | Seed |
| World Trade Ventures | Seed |
| Las Olas Venture Capital | Seed, Series A |
| 500 Global | Seed |
| Columbia University in the City of New York | Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 1, 2026
Grew 18% QoQ, from 50 to 59 employees.
- Sep 1, 2026
Grew 27% QoQ from 44 to 56 employees.
For institutional investors. Book with your work email.
AvoMD Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about AvoMD's valuation, stock price, and market status.
Is AvoMD a public or private company?
AvoMD is a private company.
What is the current stock price of AvoMD?
AvoMD is a private company, so its shares have no public market price. Caplight tracks AvoMD's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is AvoMD worth (valuation)?
Valuation information for AvoMD is not publicly available.
Can I buy AvoMD stock?
AvoMD shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was AvoMD's last funding round?
AvoMD's most recent funding round was Series A on March 31, 2026.
Who are the main investors in AvoMD?
Key investors in AvoMD include AlleyCorp, Noro-Moseley Partners.
Will AvoMD IPO soon?
No public IPO plans have been announced for AvoMD.
How can I track AvoMD secondary market activity?
Caplight tracks bids, offers, and trades in AvoMD's shares on secondary markets.